Krystal Biotech buy Chardan Capital
Start price
04.11.25
/
50%
€170.15
Target price
04.11.26
€191.16
Performance (%)
34.18%
Price
18:27
€228.30
Summary
This prediction is currently active. With a performance of 34.18% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 04.11.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 4.791% | 4.791% |
| iShares Core DAX® | 1,07 % | -0,52 % |
| iShares Nasdaq 100 | -0,49 % | -4,06 % |
| iShares Nikkei 225® | -2,03 % | 6,91 % |
| iShares S&P 500 | -0,10 % | -2,37 % |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $216.00 to $220.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25